Frequency of Hepatopulmonary Syndrome and its Associated Factors in Decompensated Liver Cirrhosis
DOI:
https://doi.org/10.1996/pjcm.v28i1.825Keywords:
Hepatopulmonary Syndrome, Cirrhosis, Child PughAbstract
Background: Pulmonary dysfunction including hepatopulmonary syndrome is an important complication of cirrhosis and portal hypertension which affects the treatment and disease prognosis. Although HPS most commonly presents in patients with cirrhosis, it has also been reported among cases of chronic hepatitis with no cirrhosis or portal hypertension. In cirrhotic cases with HPS, survival was significantly decreased compared with cirrhotic cases without HPS. Objective: The current study aimed to determine the frequency of hepatopulmonary syndrome and its associated factors in decompensated liver cirrhosis. Methodology: A descriptive, cross-sectional study was conducted at the Department of Medicine, Bahawal Victoria Hospital, Bahawalpur from May 30, 2021, to November 29, 2021. A total of 96 patients with decompensated liver cirrhosis, fulfilling the inclusion criteria were selected. Relevant history from each patient, and demographic characteristics i.e. age, gender and duration of disease were noted in each patient. After this, the child-pugh class was noted. The presence or absence of hepatopulmonary syndrome in each patient was noted. Statistical Package for Social Science was used. P-value ≤ 0.05 was considered as significant. Results: The mean age of the study participants was 39.44 ± 9.91 years. Out of the 96 patients, 82.17% were male and 17.71% were females with a male-to-female ratio of 1.3:1. Hepatopulmonary syndrome was found in 48.96% of patients. There was no association of hepatopulmonary syndrome with age, gender, duration of disease, Child pugh class and alcoholism, only a statistically significant effect of smoking on hepatopulmonary syndrome was noted. Conclusion: The current study concluded that the frequency of hepatopulmonary syndrome (HPS) in decompensated liver cirrhosis patients is 48.96% and smoking has a strong significant association.References
Roerecke M, Vafaei A, Hasan OS, Chrystoja BR, Cruz M, Lee R, et al. Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis. Am J Gastroenterol Suppl. 2019;114(10):1574.
Shi M, Li YY, Xu RN, Meng FP, Yu SJ, Fu JL, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatol Int. 2021;15:1431-41.
Chiu WC, Shan JC, Yang YH, Chen VCH, Chen PC. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder. Drug Alcohol Depend. 2021;228:109096.
Cartin-Ceba R, Krowka MJ. Pulmonary complications of portal hypertension. Clin. Liver Dis. 2019;23(4):683-711.
Dahiya DS, Kichloo A, Shaka H, Singh J, Singh G, Wani F, et al. Hepatopulmonary Syndrome: A Nationwide Analysis of Epidemiological Trends and Outcomes From 2012 to 2018. Gastroenterol Res Pract. 2021;14(4):252.
Uyeda JW. Utility of MR imaging in abdominopelvic emergencies. Radiologic Clinics. 2019;57(4):705-15.
Koch DG, Fallon MB. Hepatopulmonary syndrome. Curr Opin Gastroenterol. 2014;30(3):260-4.
Campanile A, Colombo A, Del Pinto M, Cavallini C. Persistent unexplained dyspnea: a case of hepatopulmonary syndrome. Case Reports Card. 2017;2017(1):1469893.
Tumgor G. Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol. 2014;20(10):2586-94.
Deleuran T, Vilstrup H, Jepsen P. Decreasing mortality among Danish alcoholic cirrhosis patients: a nationwide cohort study. Am J Gastroenterol. 2016;111(6):817-22.
Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplant. 2016;100(7):1440-52.
Khiangte B, Kothakota SR, Sasidharan M, Kareem H, Joshi S, Kumar VV, et al. Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease. Indian J. Gastroenterol. 2020;39:362-9.
Kim KY, Kim TH, Lee JM, Yi NJ, Kim HY, Moon JS, et al. Clinical outcomes and risk factors of hepatopulmonary syndrome in children. Sci Rep. 2021;11(1):4134.
AE Maaem, Elakad A, Ali A, Abd-Elkader M, Sayed AF, Taha A, et al. Hepatopulmonary syndrome: prevalence and predictors in Egyptian cirrhotic patients. Trop Gastroenterol. 2011;32(1):25-30.
Younis I, Sarwar S, Butt Z, Tanveer S, Qaadir A, Jadoon NA. Clinical characteristics, predictors, and survival among patients with hepatopulmonary syndrome. Ann. Hepatol. 2015;14(3):354-60.
Weinfurtner K, Forde K. Hepatopulmonary syndrome and portopulmonary hypertension: current status and implications for liver transplantation. Curr Hepatol Rep. 2020;19:174-85.
Shafiq M, Khan AA, Alam A, Butt AK, Shafqat F, Malik K, et al. Frequency of hepatopulmonary syndrome in cirrhotic patients. J Coll Physicians Surg Pak. 2008;18(5):278-81.
Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461-8.
Ferreira PP, Camara EJN, Paula RL, Zollinger CC, Cavalcanti AR, Bittencourt PL. Prevalence of hepatopulmonary syndrome in patients with decompensated chronic liver disease and its impact on short-term survival. Arq Gastroenterol. 2008;45:34-7.
Mandell SM. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transplant. 2004;10:S54-8.
Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol. 2007;5(6):749-54.
Rutledge SM, Asgharpour A. Smoking and liver disease. Gastroenterol Hepatol. 2020;16(12):617-25.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


